|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 47/26 | |||
| A61K 47/54 | |||
| A61K 38/27 | |||
| A61P 5/06 |
| (11) | Number of the document | 2981282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14715022.1 |
| Date of filing the European patent application | 2014-04-04 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/056819 |
| Date | 2014-04-04 |
| (87) | Number | WO 2014/166836 |
| Date | 2014-10-16 |
| (30) | Number | Date | Country code |
| 13162480 | 2013-04-05 | EP | |
| 201361821890 P | 2013-05-10 | US | |
| 13184957 | 2013-09-18 | EP | |
| 201361879956 P | 2013-09-19 | US |
| (72) |
NIELSEN, Jette, DK
ESKLING, Marie, DK
CHRISTENSEN, Stina Granzau, DK
H JBY, Michael, DK
OLSEN, Minna Bręndholt, DK
|
| (73) |
Novo Nordisk Health Care AG,
Thurgauerstrasse 36/38 8050 Zürich,
CH
|
| (54) | GROWTH HORMONE COMPOUND FORMULATION |
| GROWTH HORMONE COMPOUND FORMULATION |